Results 11 to 20 of about 41,383 (293)
SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden [PDF]
Journal of Translational Medicine, 2007 Native Factor V is an anticoagulant, but when activated by thrombin, Factor X or platelet proteases, it becomes a procoagulant. Due to these double properties, Factor V plays a crucial role in the regulation of coagulation/anticoagulation balance. Factor
Ferrazzi Paola +6 more
doaj +2 more sources
Factor V Leiden Mutation in Iraqi Patients with Deep Venous Thrombosis.
مجلة كلية الطب, 2011 Background: Factor V Leiden is considered the most common inherited risk factor for venous thrombosis in Caucasian populations, including those in the Eastern Mediterranean region.
Nasir Al-Allawi +2 more
doaj +3 more sources
Factor V Leiden Mutation and Stroke
Pediatric Neurology Briefs, 2001 The association of the factor V Leiden mutation and cerebrovascular disorder (CVD) in children is reviewed and the clinical features of 8 children with cerebral palsy (CP) and the Leiden mutation are described from the National Institute of Neurological ...
J Gordon Millichap
doaj +2 more sources
Factor V Leiden and Cardiopulmonary Bypass
The Journal of ExtraCorporeal Technology, 2015 We present a case of a patient with factor V Leiden with an antithrombin III activity of 67% who received a successful aortic valve replacement supported by cardiopulmonary bypass (CPB). A safe level of anticoagulation was achieved by monitoring activated clotting time (ACT) and heparin concentration ensuring adequate anticoagulation throughout the ...
Victor, Uppal +5 more
openaire +3 more sources
Factor V Leiden Mutation in Cerebrovascular Disease
Clinical and Applied Thrombosis/Hemostasis, 2005 Several studies indicate a high prevalence of factor V Leiden mutation as the most frequent coagulation defect found in patients with venous thrombosis. The relationship between this mutation and cerebrovascular disease has not been established in adults.
Buyru, N +3 more
openaire +3 more sources
Factor V Leiden Mutation and Neonatal Stroke
Pediatric Neurology Briefs, 1997 Three infants with familial factor V Leiden mutation and neonatal cerebrovascular disorders are reported from the Children’s Hospital of Philadelphia, PA.
J Gordon Millichap
doaj +2 more sources
Factor V Leiden Mutation and its Impact on Pregnancy Complications
Acta Medica, 2011 Objective: The aim of this prospective study was to find the association between the factor V Leiden mutation and adverse pregnancy outcomes. Methods: This study is an analysis of a prospective observational study of the frequency of placenta-mediated ...
Ľubica Hammerová +3 more
doaj +2 more sources
Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients
Turkish Journal of Hematology, 2011 OBJECTIVE: Budd-Chiari syndrome is a multifactorial disease in which several prothrombotic disorders may predispose patients to the development of thrombosis at this uncommon location (hepatic veins). The aim of this study was to determine the prevalence
Tawhida Y. Abdel Ghaffar +7 more
doaj +4 more sources
Regional block anesthesia in a patient with factor V Leiden mutation and axillary artery occlusion
Local and Regional Anesthesia, 2011 Kerem Erkalp1, Mevlut Comlekci1, Bekir Inan2, Gokcen Basaranoglu1, Haluk Ozdemir1, Leyla Saidoglu11Department of Anaesthesiology and Reanimation, Vakif Gureba Hospital, Istanbul, Turkey; 2Department of Vascular Surgery, Vakif Gureba Hospital, Istanbul ...
Kerem Erkalp +3 more
doaj +1 more source
Factor V Leiden and Prothrombin Mutations in South of Iran
Armaghane Danesh Bimonthly Journal, 2007 : Introduction & Objective: Factor V Leiden and prothrombin mutation are not common but they are involved in pediatric thrombosis. The aim of this study was to evaluate the frequency of factor V Leiden & prohtrombin mutation in healthy population of ...
M Karimi, AR Panahande, AR Afrasiabi
doaj +1 more source